Earnings
📈 Stocks
Samsung Biologics Raises 2026 Revenue Guidance to 20% After Strong Q3 Results
(just now)
Samsung Biologics lifts 2026 revenue growth outlook to 20% following a strong Q3 performance, supported by increased capacity at Plant 5 and…